INT-777 is a bile acid receptor agonist that has shown potential in various therapeutic applications, particularly in metabolic and inflammatory diseases. It is primarily studied for its role in improving insulin sensitivity and glucose homeostasis, making it a promising candidate for treating type 2 diabetes. Additionally, INT-777 has demonstrated anti-inflammatory properties, which could be beneficial in managing conditions like non-alcoholic steatohepatitis (NASH) and other liver-related disorders. Its ability to modulate bile acid signaling pathways also suggests potential applications in cholesterol metabolism and cardiovascular health. Research continues to explore its efficacy and safety in these areas.